您的购物车当前为空
S19-1035为AKR1C3(aldehyde ketone reductase 1C3)的高效特异性抑制剂,其IC50值为3.04 nM,主要应用于肿瘤研究。


为众多的药物研发团队赋能,
让新药发现更简单!
S19-1035为AKR1C3(aldehyde ketone reductase 1C3)的高效特异性抑制剂,其IC50值为3.04 nM,主要应用于肿瘤研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 108 | In Stock | |
| 5 mg | ¥ 232 | In Stock | |
| 10 mg | ¥ 356 | In Stock | |
| 25 mg | ¥ 721 | In Stock | |
| 50 mg | ¥ 1,130 | In Stock | |
| 100 mg | ¥ 1,650 | In Stock | |
| 200 mg | ¥ 2,390 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 257 | In Stock |
S19-1035 相关产品
| 产品描述 | S19-1035 is a potent and specific inhibitor of aldo-keto reductase 1C3 (AKR1C3), displaying an inhibitory concentration (IC50) of 3.04 nM. It is primarily utilized in tumor research. |
| 靶点活性 | AKR1C3:3.04 nM |
| 体外活性 | S19-1035在低细胞毒性条件下(0-100μM;72小时或96小时)对单独使用时的抗肿瘤效果有限。[1] 然而,当以10μM剂量连续使用8天时,S19-1035显著逆转了对阿霉素抗药的乳腺癌细胞系的抗性。[1] |
| 体内活性 | Setrobuvir(分别为200、400和800 mg)BID的活动表现为分别降低了-2.1、-2.2和-2.9 log10 IU/mL(与安慰剂相比≤0.1 log10 IU/mL)[3]。 |
| 分子量 | 356.80 |
| 分子式 | C19H17ClN2O3 |
| Smiles | Cc1noc(C)c1COc1ccccc1C(=O)Nc1ccccc1Cl |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 112.5 mg/mL (315.3 mM), Sonication and heating to 60℃ are recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容